Prediabetes drug trial aims to stop diabetes before it starts
NCT ID NCT07392151
First seen Feb 06, 2026 · Last updated May 22, 2026 · Updated 14 times
Summary
This study tests if glucose-lowering drugs (semaglutide and dapagliflozin) can return blood sugar to normal in people with prediabetes and heart disease. About 158 adults will either get the medication plus lifestyle advice or standard care. The goal is to see if treatment can prevent diabetes and reduce damage to eyes, kidneys, and nerves.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREDIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus University Hospital
Aarhus N, 8200, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.